387 related articles for article (PubMed ID: 30360879)
1. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
Devan J; Janikova A; Mraz M
Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
[TBL] [Abstract][Full Text] [Related]
3. [Novel Findings in Follicular Lymphoma Pathogenesis and the Concepts of Targeted Therapy].
Deván J; Musilová K; Janíková A; Mráz M
Klin Onkol; 2017; 30(4):247-257. PubMed ID: 28832170
[TBL] [Abstract][Full Text] [Related]
4. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
[TBL] [Abstract][Full Text] [Related]
5. Follicular lymphoma: The long and winding road leading to your cure?
Gordon MJ; Smith MR; Nastoupil LJ
Blood Rev; 2023 Jan; 57():100992. PubMed ID: 35908982
[TBL] [Abstract][Full Text] [Related]
6. Premalignant cell dynamics in indolent B-cell malignancies.
Milpied P; Nadel B; Roulland S
Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathways in follicular lymphoma.
Bende RJ; Smit LA; van Noesel CJ
Leukemia; 2007 Jan; 21(1):18-29. PubMed ID: 17039231
[TBL] [Abstract][Full Text] [Related]
8. Critical influences on the pathogenesis of follicular lymphoma.
Küppers R; Stevenson FK
Blood; 2018 May; 131(21):2297-2306. PubMed ID: 29666116
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of follicular lymphoma.
Kishimoto W; Nishikori M
J Clin Exp Hematop; 2014; 54(1):23-30. PubMed ID: 24942943
[TBL] [Abstract][Full Text] [Related]
10. Exploration of factors affecting the onset and maturation course of follicular lymphoma through simulations of the germinal center.
Fenwick MK; Escobedo FA
Bull Math Biol; 2009 Aug; 71(6):1432-62. PubMed ID: 19412639
[TBL] [Abstract][Full Text] [Related]
11. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma.
Akasaka T; Lossos IS; Levy R
Blood; 2003 Aug; 102(4):1443-8. PubMed ID: 12738680
[TBL] [Abstract][Full Text] [Related]
12. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
[TBL] [Abstract][Full Text] [Related]
13. The routes for transformation of follicular lymphoma.
Okosun J; Montoto S; Fitzgibbon J
Curr Opin Hematol; 2016 Jul; 23(4):385-91. PubMed ID: 27135979
[TBL] [Abstract][Full Text] [Related]
14. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
15. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
Chung C
J Oncol Pharm Pract; 2020 Jun; 26(4):943-966. PubMed ID: 31964218
[TBL] [Abstract][Full Text] [Related]
16. [The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma].
Musilová K; Deván J; Zlámalíková L; Křen L; Móciková H; Procházka V; Mayer J; Trněný M; Janíková A; Mráz M
Klin Onkol; 2017; 30(Supplementum1):163-165. PubMed ID: 28471196
[TBL] [Abstract][Full Text] [Related]
17. Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression.
Sungalee S; Mamessier E; Morgado E; Grégoire E; Brohawn PZ; Morehouse CA; Jouve N; Monvoisin C; Menard C; Debroas G; Faroudi M; Mechin V; Navarro JM; Drevet C; Eberle FC; Chasson L; Baudimont F; Mancini SJ; Tellier J; Picquenot JM; Kelly R; Vineis P; Ruminy P; Chetaille B; Jaffe ES; Schiff C; Hardwigsen J; Tice DA; Higgs BW; Tarte K; Nadel B; Roulland S
J Clin Invest; 2014 Dec; 124(12):5337-51. PubMed ID: 25384217
[TBL] [Abstract][Full Text] [Related]
18. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection.
Cong P; Raffeld M; Teruya-Feldstein J; Sorbara L; Pittaluga S; Jaffe ES
Blood; 2002 May; 99(9):3376-82. PubMed ID: 11964306
[TBL] [Abstract][Full Text] [Related]
19. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.
Li H; Kaminski MS; Li Y; Yildiz M; Ouillette P; Jones S; Fox H; Jacobi K; Saiya-Cork K; Bixby D; Lebovic D; Roulston D; Shedden K; Sabel M; Marentette L; Cimmino V; Chang AE; Malek SN
Blood; 2014 Mar; 123(10):1487-98. PubMed ID: 24435047
[TBL] [Abstract][Full Text] [Related]
20. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.
Correia C; Schneider PA; Dai H; Dogan A; Maurer MJ; Church AK; Novak AJ; Feldman AL; Wu X; Ding H; Meng XW; Cerhan JR; Slager SL; Macon WR; Habermann TM; Karp JE; Gore SD; Kay NE; Jelinek DF; Witzig TE; Nowakowski GS; Kaufmann SH
Blood; 2015 Jan; 125(4):658-67. PubMed ID: 25452615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
